CS logo
small CS logo
Specjalistyczny Szpital im. Alfreda Sokolowskiego

Szczecin, Zachodniopomorskie, Poland
Hospital in Szczecin
Alfreda Sokołowskiego 11, 71-899 Szczecin

About Specjalistyczny Szpital im. Alfreda Sokolowskiego


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Achieve Life Sciences
1
Alaunos Therapeutics
1
Astex Pharmaceuticals, Inc.
1
Gilead Sciences
1
Morphotek
1
NovoCure GmbH
1
Wellspect HealthCare
1
Total Rows: 7

Clinical Trials at Specjalistyczny Szpital im. Alfreda Sokolowskiego


During the past decade, Specjalistyczny Szpital im. Alfreda Sokolowskiego conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201600.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Study to Investigate if Transfusion of Patients Own Shed Blood Improves the Immunological Status in Comparison to Transfusion of Donor Blood ("Bank Blood")
2009-01-01
2009-06-01
Completed
45
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
2011-06-27
2013-11-01
Completed
130
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
2010-10-01
2013-09-01
Completed
324
A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer
2011-05-01
2012-05-28
Completed
23
Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)
2012-05-01
2015-06-01
Unknown status
548
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
2012-09-01
2017-07-01
Unknown status
700
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
2016-12-01
2023-09-01
Active, not recruiting
276

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Specjalistyczny Szpital im. Alfreda Sokolowskiego" #1 sponsor was "Achieve Life Sciences" with 1 trials, followed by "Alaunos Therapeutics" with 1 trials sponsored, "Astex Pharmaceuticals, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Morphotek" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
Created with Highcharts 11.1.0Top Leading SponsorsAchieve Life Sciences: 1Achieve Life Sciences: 1Alaunos Therapeutics: 1Alaunos Therapeutics: 1Astex Pharmaceuticals, Inc.: 1Astex Pharmaceuticals, Inc.: 1Gilead Sciences: 1Gilead Sciences: 1Morphotek: 1Morphotek: 1NovoCure GmbH: 1NovoCure GmbH: 1Wellspect HealthCare: 1Wellspect HealthCare: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Specjalistyczny Szpital im. Alfreda Sokolowskiego


According to Clinical.Site data, the most researched conditions in "Specjalistyczny Szpital im. Alfreda Sokolowskiego" are "Adenocarcinoma of the Lung" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Blood Transfusion" (1 trials), "Blood Transfusion, Autologous" (1 trials) and "Chronic Hepatitis C Infection" (1 trials). Many other conditions were trialed in "Specjalistyczny Szpital im. Alfreda Sokolowskiego" in a lesser frequency.

Clinical Trials Intervention Types at Specjalistyczny Szpital im. Alfreda Sokolowskiego


Most popular intervention types in "Specjalistyczny Szpital im. Alfreda Sokolowskiego" are "Drug" (6 trials), "Biological" (2 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Allogenic Blood Transfusion" (1 trials), "Amuvatinib" (1 trials), "Bellovac ABT" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Specjalistyczny Szpital im. Alfreda Sokolowskiego


The vast majority of trials in "Specjalistyczny Szpital im. Alfreda Sokolowskiego" are 7 trials for "All" genders.

Clinical Trials Status at Specjalistyczny Szpital im. Alfreda Sokolowskiego


Currently, there are NaN active trials in "Specjalistyczny Szpital im. Alfreda Sokolowskiego". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Specjalistyczny Szpital im. Alfreda Sokolowskiego, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Specjalistyczny Szpital im. Alfreda Sokolowskiego, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Phase 3: 3Phase 3: 3Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Unknown status: 2Unknown status: 2Active, not recruiting: 1Active, not recruiting: 1